贾 斌, 张真发, 王长利. 370 例肺腺癌各亚型间临床及预后影响因素的比较[J]. 中国肿瘤临床, 2009, 36(2): 61-64. DOI: 10.3969/j.issn.1000-8179.2009.02.001
引用本文: 贾 斌, 张真发, 王长利. 370 例肺腺癌各亚型间临床及预后影响因素的比较[J]. 中国肿瘤临床, 2009, 36(2): 61-64. DOI: 10.3969/j.issn.1000-8179.2009.02.001
JIA Bin, ZHANG Zhenfa, WANG Changli. Comparison of Clinical Features and Prognostic Factors among Different Histological Subtypes of Lung Adenocarcinoma: An Analysis of370 Cases[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 36(2): 61-64. DOI: 10.3969/j.issn.1000-8179.2009.02.001
Citation: JIA Bin, ZHANG Zhenfa, WANG Changli. Comparison of Clinical Features and Prognostic Factors among Different Histological Subtypes of Lung Adenocarcinoma: An Analysis of370 Cases[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 36(2): 61-64. DOI: 10.3969/j.issn.1000-8179.2009.02.001

370 例肺腺癌各亚型间临床及预后影响因素的比较

Comparison of Clinical Features and Prognostic Factors among Different Histological Subtypes of Lung Adenocarcinoma: An Analysis of370 Cases

  • 摘要: 目的:根据WHO2004年对于肺腺癌分型的最新定义标准,探讨肺腺癌各亚型之间预后的差异及预后因素。方法:收集本院2000年1 月至2003年12月期间行手术治疗的370 例肺腺癌患者病理切片,并对其临床资料进行回顾性分析,对患者的生存时间进行随访;采用Kaplan-Meier 法计算生存率,采用COX 模型进行多因素分析。结果:全组患者术后5 年总体生存率25.26% ,中位生存期3.89年;单因素分析结果显示:病理亚型、支气管断端是否阳性、肿瘤直径、TNM分期、T 分期、N 分期、术后是否行化疗、免疫治疗对全组患者总体生存率的影响有统计学意义;多因素分析显示:术后病理亚型、气管断端是否阳性,TNM分期、肿瘤直径、是否行化疗为影响患者总体生存率的独立因素。各亚型之间分析显示:单纯型细支气管肺泡癌(Bronchioloalveolarcarcinoma ,BAC )的5 年生存率为41.30% ,优于其它类型腺癌(P=0.002);无BAC 成份的各亚型腺癌的预后差异无统计学意义;含BAC 的混合型腺癌预后介于前两者之间。结论:手术仍为肺腺癌的主要治疗手段;含BAC 的混合型腺癌预后介于BAC 与无BAC 成份的其他类型腺癌,可视为独立的病理类型;术后病理亚型、气管断端是否阳性,TNM分期、肿瘤直径、化疗为影响患者总体生存率的独立因素。

     

    Abstract: Objective: To analyze the clinical features and prognostic factors of different histological sub -types of lung adenocarcinoma. Methods:Data from 370 lung adenocarcinoma patients who underwent surgi-cal resection for pathologically supported adenocarcinoma in our hospital between 2000and 2003were retro spectively reviewed. The Kaplan-Meier method was used to estimate patient survival, and Cox’s proportional hazards model was performed for multivariate analysis. Results: The 5-year overall survival rate was 25.26%, and the mean survival time was3.89years. In multivariate analysis, histological subtype, incised margin resid -ual, TNM stage, tumor size, and adjuvant chemotherapy were identified as independent survival predictors. The 5-year survival rate in bronchioloalveolar adenocarcinoma (BAC) patients was 41.30%, higher than in pa-tients with other subtypes of lung adenocarcinoma (P=0.002 ). No significant difference was found in the prog -nosis among patients with different subtypes of adenocarcinoma without a BAC component.Conclusion:Ade -nocarcinoma with a BAC component is an independent subtype of lung adenocarcinoma. Its prognosis lies be-tween those of BAC and adenocarcinoma without BAC. Histological subtype, incised margin residual, TNM stage, tumor size, and adjuvant chemotherapy are independent survival predictors.

     

/

返回文章
返回